Effects of Vibration on Early Mobilization of Cardiac Surgery Patients
"Pilot Study: Effects of Vibration on Postoperative Early Mobilization of Cardiac Surgery Patients"
This study tests if using vibration therapy on the feet can help patients who just had heart surgery move around better and feel less dizzy during their recovery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 65 Years to 85 Years |
| Sex | All |
| Sponsor | Medical University of Graz Academic / other |
| Locations | 1 site (Graz, Styria) |
| Trial ID | NCT04243213 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of vibration therapy on the early mobilization of patients who have undergone cardiac surgery. It aims to determine if vibrations applied to the soles of the feet can enhance postural control and reduce dizziness during the critical early postoperative period. Thirty patients will be randomly assigned to one of three groups: one receiving vibration therapy, another positioned at a tilt without vibration, and a control group receiving standard physiotherapy. The study will measure cardiovascular regulation and mobilization outcomes over the first week post-surgery.
Who should consider this trial
Good fit: Ideal candidates are patients undergoing elective cardiac surgeries such as aortic valve replacement or coronary bypass.
Not a fit: Patients with high surgical risk scores, postoperative delirium, or those requiring high-dose catecholamines may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved recovery times and reduced complications for cardiac surgery patients.
How similar studies have performed: Preliminary studies suggest that vibration therapy may positively influence cardiovascular regulation, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who undergo heart surgery: aortic valve replacement or elective coronary bypass Exclusion Criteria: * Euroscore II \> 8 * patients with a postop. delirium on day 2 (drug treatment) * Patients who require higher-dose catecholamines 48h post surgery (norepinephrine over 0.05-0.1 micrograms / kg body weight, suprarenin over 0.05-0.1 micrograms / kg body weight, Dobutrex over 5 micrograms / kg body weight) * existing thrombosis
Where this trial is running
Graz, Styria
- Medical University of Graz — Graz, Styria, Austria (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.